91 related articles for article (PubMed ID: 23690099)
1. The evaluation of coagulation parameters and vessel involvement in Behcet' s disease. A clinical experience of Behcet' s disease: study of 152 cases.
Harman E; Sayarlıoglu M; Harman M; Sayarlıoglu H
Acta Med Iran; 2013 May; 51(4):215-23. PubMed ID: 23690099
[TBL] [Abstract][Full Text] [Related]
2. High levels of endothelial progenitor cells can be associated with thrombosis in patients with Behçet's disease.
Bozkirli ED; Keşkek SÖ; Kozanoğlu I; Yücel AE
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S49-53. PubMed ID: 24774036
[TBL] [Abstract][Full Text] [Related]
3. Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement.
Sengül N; Demirer S; Yerdel MA; Terzioğlu G; Akin B; Gürler A; Tüzüner A
World J Surg; 2000 Dec; 24(12):1584-8. PubMed ID: 11193728
[TBL] [Abstract][Full Text] [Related]
4. Lipid profile and anticardiolipin antibodies in Behcet's disease.
Musabak U; Baylan O; Cetin T; Yesilova Z; Sengul A; Saglam K; Inal A; Kocar IH
Arch Med Res; 2005; 36(4):387-92. PubMed ID: 15950080
[TBL] [Abstract][Full Text] [Related]
5. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.
Fernández-Bello I; López-Longo FJ; Arias-Salgado EG; Jiménez-Yuste V; Butta NV
Orphanet J Rare Dis; 2013 May; 8():81. PubMed ID: 23711081
[TBL] [Abstract][Full Text] [Related]
7. Is there a relation between clinical disease activity and acute phase response in Behcet's disease?
Melikoglu M; Topkarci Z
Int J Dermatol; 2014 Feb; 53(2):250-4. PubMed ID: 24261602
[TBL] [Abstract][Full Text] [Related]
8. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
9. Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4.
Alli N; Gur G; Yalcin B; Hayran M
Am J Clin Dermatol; 2009; 10(6):411-8. PubMed ID: 19824742
[TBL] [Abstract][Full Text] [Related]
10. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine in vascular Behcet disease: a meta-analysis.
La Regina M; Orlandini F; Prisco D; Dentali F
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2067-74. PubMed ID: 20634474
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C resistance and its correlation with thrombophlebitis in Behçet's disease.
Kavala M; Namdar ND; Kocatürk E; Türkoğlu Z; Zindanci I
Acta Dermatovenerol Croat; 2011; 19(2):87-90. PubMed ID: 21703154
[TBL] [Abstract][Full Text] [Related]
14. Serum homocysteine level is higher in Behçet's disease with vascular involvement.
Ateş A; Aydintuğ O; Olmez U; Düzgün N; Duman M
Rheumatol Int; 2005 Jan; 25(1):42-4. PubMed ID: 14586553
[TBL] [Abstract][Full Text] [Related]
15. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
16. [Venous involvement in Behcet's disease: a series of 28 cases].
Jamoussi SK; Chaaba H; Ben Dhaou B; Kochbati S; Boussema F; Cherif O; Rokbani L
Tunis Med; 2009 Dec; 87(12):829-33. PubMed ID: 20209850
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte deformability does not seem to be altered in Behçet's disease.
Simó M; Ricart JM; Santaolaria M; Ortí G; Vayá A
Clin Hemorheol Microcirc; 2007; 36(1):83-8. PubMed ID: 17211064
[TBL] [Abstract][Full Text] [Related]
18. Presence of low lipid levels in patients with Behcet' s disease as a protector against atherosclerosis.
Kayatas K; Karatoprak C; Cebeci F; Dayan A; Ozkan S; Pehlevan SM; Kartal I; Demirtunc R
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2330-4. PubMed ID: 24065226
[TBL] [Abstract][Full Text] [Related]
19. Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.
Ricart JM; España F; Navarro S; Todolí J; Miguel De la Fuente J; Vayá A
Clin Hemorheol Microcirc; 2013 Jan; 54(1):51-7. PubMed ID: 22750994
[TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine level in patients with Behcet's disease with or without thrombosis.
Shahram F; Faridar A; Hamedani MG; Nadji A; Naderi N; Mojarad Shafiee N; Rasker JJ; Davatchi F
Arch Iran Med; 2010 Nov; 13(6):476-81. PubMed ID: 21039001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
